×

Betting on biotechs: When is the time to invest?

12:47 PM ET Mon, 26 Sept 2016

CNBC's Meg Tirrell reports the latest developments in Mylan's EpiPen pricing scandal. The "FMHR" traders and Jim Cramer weigh in.